Information Provided By: 
Fly News Breaks for July 17, 2019
EKTAY, VRAY
Jul 17, 2019 | 11:36 EDT
Jefferies analyst Anthony Petrone noted that Elekta's (EKTAY) "Urgent Field Safety Notification" for its MR-Unity was officially classified as a Class 2 device recall by the FDA on Tuesday night. Petrone sees this recall potentially pushing orders towards ViewRay's (VRAY) MRIdian, increasing order flow into the back half of the year. The analyst maintained a Buy rating and $14 price target on ViewRay, and kept a Hold rating on Elekta.
News For VRAY;EKTAY From the Last 2 Days
There are no results for your query VRAY;EKTAY
